The Executive Committee (EC) is comprised of the Director, the Co-Director, the Director of Operations, Leads designated from each Core, the Lead of the linked KL2, the community co-Chair of the CAB and the Lead of the Evaluation and Continuous Improvement module (see organizational chart below). Each member is vital to ensure representation from the partner institutions, the functional units within the CTSI-CN, and the community, as well as to promote transparency, integration, and balanced decision-making. The EC will identify issues, barriers, and potential pitfalls and recommend actions to the Director regarding CTSI-CN personnel additions/changes, the progress of the modules, and priorities for developing new initiatives, technologies, and methodologies.
| Committee Member | Institution | Leadership Role |
|---|---|---|
| Lisa Guay-Woodford, MD | Children's National Hospital | Director |
| Reamer L. Bushardt, PharmD, PA-C, DFAAPA | Geoge Washington University | Interim GW Co-Director |
| Kevin Cleary, PhD | Children's National Hospital | Lead, Community and Collaboration Core |
| Reamer Bushardt, PharmD, PA-C, DFAAPA | Geoge Washington University | Lead, Translational Endeavors Core |
| James Bost, PhD | Children's National Hospital | Lead, Biostatistics, Epidemiology, and Research Design Module |
| Adelaide Robb, MD | Children's National Hospital | Lead, Network Capacity Core |
| Naomi Luban, MD | Children's National Hospital | Program Lead, KL2 |
| Karen McDonnell, PhD (ex officio) | Geoge Washington University | Lead, Evaluation and Continuous Improvement Module |
